Category: Clinical Breakthroughs
-
Hot Cocoa Aids Walking in Peripheral Artery Disease
Drinking flavanol-rich cocoa three times a day improved walking distance in individuals with peripheral artery disease, reports a new Northwestern Medicine pilot study published in Circulation Research.
-
No Coronavirus Transmission in Womb, Study Says
A new study has found no evidence that the 2019 novel coronavirus, COVID-19, is passed from women in their third trimester to the fetus in the womb.
-
Novel Drug Reduces Menstrual Bleeding from Uterine Fibroids
Elagolix, a newly developed orally administered drug, was effective in reducing heavy menstrual bleeding in women with uterine fibroids, according to a recent Northwestern Medicine clinical trial.
-
Common Supplements Fail to Increase Male Fertility
Zinc and folic acid supplements had no effect on live birth outcomes or semen quality measures, according to a recent clinical trial.
-
Reducing Dangerous Swelling in Traumatic Brain Injury
Northwestern Medicine scientists were able to significantly reduce brain swelling and damage after a traumatic brain injury by injecting nanoparticles into the bloodstream.
-
Dangerous Skin Tumor Now Has Treatment Guidelines
A Northwestern Medicine study reports the first guidelines for treating sebaceous carcinoma, a cancer of the oil glands diagnosed in thousands of patients every year.
-
Healthcare Providers Can Play a Role in Safe Firearm Storage
Northwestern investigators led by fourth-year student Grace Haser found that a majority of adult gun owners in a Chicago neighborhood with high rates of firearm violence favored firearm safety counseling offered in healthcare settings.
-
Northwestern Helps Develop Custom Drug
A one-of-a-kind drug created to treat a single patient passed a crucial test at Northwestern, according to a study published in the New England Journal of Medicine.
-
Combination Treatment Beats Chemotherapy in Breast Cancer
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
-
New Molecule Blocks ‘Undruggable’ Cancer Protein
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
